Virtual Clinical Trials – Unifying Trials from Patient Engagement Through Study Closeout

News

17 Aug 2021

Virtual Clinical Trials – Unifying Trials from Patient Engagement Through Study Closeout

Are you interested in Virtual Trials? You have heard about it, but not sure whether this approach is the most appropriate for you? You want to know how to increase patient compliance and data quality? We are happy to announce our upcoming webinar at XTalks on Monday, September 20, 2021, 10am EDT (NA) / 3pm […]

Read more
Discrete Choice Experiment: How to Run a Preference Study with the DCE Methodology

News

8 Jun 2021

Discrete Choice Experiment: How to Run a Preference Study with the DCE Methodology

Are you interested in Preference studies? You have heard about DCE, but not sure whether this approach is the most appropriate for you? You want to know how to define such a project and understand outcomes you would expect from? We are happy to announce our upcoming webinar at XTalks on Friday, June 25, 2021, […]

Read more
How to Select CTMS that will Positively Impact the Quality of your Study

News

12 Apr 2021

How to Select CTMS that will Positively Impact the Quality of your Study

The global usage of the clinical trial management system (CTMS) is increasing thanks to its outcome’s significance and efficiency. It lessens the cost of the amount invested In managing clinical trials. Reports indicate that the CTMS market’s valuation will grow from $570 million in 2019 to a projected rate of $1.4 billion by 2026. Major […]

Read more
EvidentIQ group to launch new eCOA and eFeasibility offerings combining scientific services with a comprehensive software suite usable on any device.

Press Releases

15 Mar 2021

EvidentIQ group to launch new eCOA and eFeasibility offerings combining scientific services with a comprehensive software suite usable on any device.

HAMBURG, Germany,  March 15th, 2021 – Data science group EvidentIQ with operations in Germany, France and the US, announced today the launch of their next generation eCOA and eFeasibility solutions for CROs and study sponsors. In a rapidly growing market, the EvidentIQ offering stands out as it combines a comprehensive tech stack with proven scientific […]

Read more
Newly formed data science group created from XClinical, Carenity, and Fortress Medical, to rename as EvidentIQ Group, and brings two life science veterans onboard

Press Releases

9 Feb 2021

Newly formed data science group created from XClinical, Carenity, and Fortress Medical, to rename as EvidentIQ Group, and brings two life science veterans onboard

MUNICH, Germany, Feb. 9th, 2021 – The newly formed life science group that resulted from the merger of clinical software vendors XClinical and Fortress Medical with social platform Carenity, announced to rename itself to EvidentIQ Group. The EvidentIQ offering brings an innovative end to end eClinical solution that meets increasing customer demand across clinical operations […]

Read more
XClinical to merge with Carenity and Fortress Medical Systems forming a new data science company serving life science markets worldwide

Press Releases

21 Jan 2021

XClinical to merge with Carenity and Fortress Medical Systems forming a new data science company serving life science markets worldwide

MUNICH, Germany, Jan. 20, 2021 — XClinical, a leading vendor of eClinical software has announced a merger with France-based Carenity, a social platform supporting patients and caregivers worldwide, and Fortress Medical Systems, the US-based vendor of Clindex®, an integrated CTMS and EDC system. All three companies are long-established, leading providers in their respective markets. The […]

Read more
Health Authority Platforms for Clinical Trial Information

News

20 Jan 2021

Health Authority Platforms for Clinical Trial Information

The European Medicines Agency updated the Clinical Trial Regulation (Regulation EU No. 536/2014) to ensure that clinical trials are executed in the subjects’ best interest. Although the regulation went into effect on 16 June 2014, its application depends on the release of the EU clinical trials portal “Clinical Trials Information System (CTIS).” Together with other […]

Read more
Join our Free Webinar on January 28, 2021

News

15 Jan 2021

Join our Free Webinar on January 28, 2021

11am EST (NA) / 4pm GMT (UK) / 5pm CET (EU-Central) DEMYSTIFYING CLINICAL SYSTEMS INTEGRATION Clinical trials have become extremely complex, as have clinical systems. Their integration becomes a priority to maintain consistency and to gain efficiency in data collection. Often, mid-size pharma and biotech companies believe that such integration might be beyond their reach […]

Read more
Important Regulatory Pathways for Accelerated Approval

News

5 Oct 2020

Important Regulatory Pathways for Accelerated Approval

– Takes about 6 minutes to read this topic – The U.S. FDA has implemented various programs that help to deliver safe and effective therapies to patients in need.These programs cover a broad spectrum of topics and provide additional pathways and/or support for innovative science. In this blog, we’ll discuss several important and well-known programs and their […]

Read more
Why it’s best to do eCRF design for clinical trials

News

9 Sep 2020

Why it’s best to do eCRF design for clinical trials

– Takes 10 minutes to read this topic – What’s the background on eCRFs? Electronic case report forms (eCRFs) are used for gathering patient data during clinical trials. They play a crucial role in helping to assess the safety and efficacy of clinical products. For a study to be successful, data collected must be correct and complete. To be correct […]

Read more
Adaptive Trial Design

News

26 Aug 2020

Adaptive Trial Design

– Takes about 4 minutes to read this topic – As long as their trials are well-designed and based on prior data, safeguard participants, and meet all current federal standards, drug developers have wide latitude in clinical trial design. Though clinical trials still largely follow traditional designs, some notable advances made over the last two decades are having […]

Read more
From Tragedy Came Progress

News

8 Jul 2020

From Tragedy Came Progress

– Takes 6 minutes to read this topic – In the early 20th century, the scientific community advocated for the use of “well-controlled” therapeutic drug trials. These relied on laboratory analysis followed by clinical testing in animals and humans. But the development of these drug trials was helped along by some of the darkest episodes in the history of […]

Read more

Get a Demo

Let us show you how we can help you.

Get a Quote

Discover a solution tailored to your needs and budget.

Get a Meeting

Let’s start a new project together!

Let’s Start
a conversation

Ready to discover how our platform and its suite of applications can meet your needs?

    Request

    We use cookies to personalize content and ads, provide social media features, and analyze traffic to our website. Our partners may combine this information with other data they have provided to you or collected from your use of the services. Because we value your privacy, we hereby request your permission to use the following technologies. You may change / revoke your consent later at any time by clicking on the settings in the lower left corner of the page.

    Please note that according to a recent ruling by the European Court of Justice (ECJ), there is no adequate level of data protection in the USA and therefore a risk to the protection of your data. For example, under certain conditions, your data may be processed by US authorities for control and monitoring purposes. In addition, we currently refer to Art. 49 GDPR with regard to the legal basis for the transfer of data. After implementation of the new EU standard data protection clauses, these will constitute the legal basis for data transfer to third countries.

    OK